Traders should anticipate lower liquidity and higher volatility post-split due to the reduced share count. Monitor for potential NASDAQ uplisting or improved investor perception, but be cautious of typical reverse split risks such as reduced retail investor interest.
Price Chart
Executive Summary
VolitionRx Limited announced a one-for-twenty reverse stock split of its common stock, effective April 28, 2026. The move is tied to financing agreements with Lind Global Asset Management and aims to meet listing or capital structure requirements.
Key Facts
- VolitionRx is executing a one-for-twenty reverse stock split of its common stock
- The reverse stock split is effective on April 28, 2026, at 12:01 a.m. ET
- The action follows shareholder approval on March 31, 2026, and is linked to financing deals with Lind Global Asset Management on May 20, 2025, and January 15, 2026
- No fractional shares will be issued; holders receiving fractional shares will get one whole share
- All outstanding equity instruments, including warrants, options, and convertible notes, will be proportionally adjusted
Financial Impact
The reverse stock split will reduce the number of outstanding shares by 95% (one-for-twenty), increasing the per-share price proportionally without changing the company's market cap of $28M
Risk Factors
- Reverse stock splits are often perceived negatively by the market as they can signal financial distress
- Reduced share count may lead to lower trading volume and increased volatility
- Potential delisting risk if the company fails to meet continued listing standards despite the split
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-002373 |
| Document: 0001477932-26-002373-index-headers.html | 0001477932-26-002373 |
| Document: 0001477932-26-002373-index.html | 0001477932-26-002373 |
| Document: 0001477932-26-002373.txt | 0001477932-26-002373 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $0.2529 | awaiting T+60 | — | $0.1800 (+28.83%) |
Sep 16, 2026 5w ago | SC 13D/A | $0.2849 | awaiting T+60 | — | $0.1800 (−36.82%) |
Sep 15, 2026 5w ago | 8-K | $0.2749 | awaiting T+60 | — | $0.1800 (+34.52%) |
Sep 11, 2026 6w ago | EFFECT | $0.3102 | awaiting T+60 | — | $0.1800 (+41.97%) |
Sep 8, 2026 6w ago | S-3/A | $0.3400 | awaiting T+60 | — | $0.1800 (+47.06%) |
Sep 1, 2026 7w ago | 8-K | $0.3800 | awaiting T+60 | — | $0.1800 (+52.63%) |
Aug 24, 2026 9w ago | 8-K | $0.3846 | awaiting T+60 | — | $0.1800 (+53.20%) |
Aug 7, 2026 11w ago | 8-K | $0.7700 | awaiting T+60 | — | $0.1800 (+76.62%) |
Jul 20, 2026 14w ago | EFFECT | $1.13 $0.1847 | ▲ +83.65% | ▲ +88.50% | $0.1800 (+84.07%) |
Jun 18, 2026 18w ago | 8-K | $1.34 | awaiting T+60 | — | $0.1800 (+86.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers